13F Data
13F filer · CIK 1400240

Flagship Pioneering, LLC

CAMBRIDGE, MA · filing since Q3 2016 · last filing Aug 14, 2026
Reported value
$1.5B
+$378.3M vs prior
Positions
5
New / sold out
0 / 0
Added / reduced
0 / 0
Turnover
0.0%
buys $0 · sells $0
Top-10 weight
100.0%

Biggest buys vs Q1 2026

No new or increased positions this quarter.

Biggest sells vs Q1 2026

No reduced or sold positions this quarter.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q3 2016: $366.0MQ4 2016: $307.3MQ1 2017: $376.3MQ2 2017: $283.6MQ3 2017: $299.0MQ4 2017: $394.3MQ1 2018: $344.9MQ2 2018: $522.1MQ3 2018: $1.5BQ4 2018: $2.0BQ1 2019: $2.6BQ2 2019: $2.3BQ3 2019: $892.0MQ4 2019: $1.8BQ1 2020: $2.1BQ2 2020: $3.4BQ3 2020: $3.6BQ4 2020: $5.5BQ1 2021: $6.2BQ2 2021: $7.8BQ3 2021: $9.5BQ4 2021: $6.5BQ1 2022: $4.3BQ2 2022: $2.7BQ3 2022: $2.4BQ4 2022: $3.1BQ1 2023: $2.6BQ2 2023: $2.2BQ3 2023: $1.4BQ4 2023: $1.3BQ1 2024: $1.5BQ2 2024: $843.4MQ3 2024: $591.9MQ4 2024: $334.2MQ1 2025: $235.8MQ2 2025: $268.5MQ3 2025: $292.6MQ4 2025: $324.0MQ1 2026: $1.2BQ2 2026: $1.5B
Q3 2016Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1GENERATE BIOMEDICINES INCCOM SHS62,673,117$1.1B68.66%
2MODERNA INCCOM4,632,149$324.4M21.07%
3SANA BIOTECHNOLOGY INCCOM25,001,856$87.3M5.67%
4FOGHORN THERAPEUTICS INCCOM12,674,120$61.8M4.02%
5SERES THERAPEUTICS INCCOM NEW1,155,850$9.1M0.59%